ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Discovery of a novel GRPR antagonist for protection against cisplatin-induced acute kidney injury

Yu, Ming-jun; Li, Chao; Deng, Sheng-song; Meng, Xiao-ming; Yao, Ri-sheng*安徽医科大学
Bioorganic Chemistry2022-7DOI: 10.1016/j.bioorg.2022.105794
2被引9阅读
引用收藏
分享

摘要

The side effects of acute Kidney Injury (AKI) and nephrotoxicity limit the application of cisplatin in cancer treatment. Inflammation and oxidative stress paly important role in the pathogenesis of cisplatin-induced AKI. Gastrin-releasing peptide receptor (GRPR) plays an important role in inflammatory response. In this study, we designed 34 new Pd176252 analogs, most synthesized compounds could reduce cisplatin-induced HK2 cell death. Of these compounds, 9b had strong binding affinity with GRPR, and significantly increased HK2 cell viability. Compound 9b significantly downregulated the level of creatinine, blood urea nitrogen (BUN), and malondialdehyde (MDA), and recovered the glutathione (GSH) level in cisplatin-induced AKI model. It also decreased the level of kidney injury molecule-1(KIM-1) in vitro and vivo. In the further pathogenesis studies, 9b downregulated level of inflammatory factors (TNF-alpha, IL-113, IL-6 and MCP-1), suppressed the nuclear factor kappa B (NF-kB) phosphorylation, and decreased GRPR level. The results suggested that ameliorating cisplatin-induced AKI actions of 9b was involved in downregulation of TNF-alpha, IL-113, IL-6, and MCP-1, inhibition of NF-kB activation, and reduction of GRPR and oxidative stress level.

学科与关键词

关键词
Acute kidney injuryGRPRPd176252Cisplatin
相关
加载中…
  • Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis
    Li, Chao; Ma, Qiu-ying; Liu, Xue-qi; Li, Hai -di; Yu, Ming-jun; Xie, Shuai-shuai; Ma, Wen-xian; Chen, Ying; Wang, Jia-nan; He, Ruo-bing; Bian, He-ge; He, Yuan; Gao, Li; Deng, Sheng-song; Zang, Hong-mei; Gong, Qian; Wen, Jia-gen; Liu, Ming-ming; Yang, Chen; Chen, Hai-yong; Li, Jun; Lan, Hui-yao; Jin, Juan*; Yao, Ri-sheng*; Meng, Xiao-ming*Molecular Therapy, 2023, 31(9): 2734-2754.被引 1
  • MicroRNA-483-5p accentuates cisplatin-induced acute kidney injury by targeting GPX3
    Xia, Ying; Pan, Wenbin; Xiao, Xiao; Zhou, Xuejuan; Gu, Wenqing; Liu, Yaqin; Zhao, Yanyan; Li, Lixia; Zheng, Chenghao; Liu, Jun*; Li, Ming*Laboratory Investigation, 2022, 102(6): 589-601.被引 8
  • Hyperoside ameliorates cisplatin-induced acute kidney injury by regulating the expression and function of Oat1
    Yuan, Wenjing; Kou, Shanshan; Ma, Ying; Qian, Yusi; Li, Xinyu; Chai, Yuanyuan; Jiang, Zhenzhou; Zhang, Luyong; Sun, Lixin; Huang, Xin*Xenobiotica; the fate of foreign compounds in biological systems, 2023, 53(8-9): 559-571.
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic Chemistry
发表日期
2022-07
卷期
第 124 卷
页码
105794
DOI
10.1016/j.bioorg.2022.105794
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Key Program of Natural Science Research by Education Department of Anhui Province of China [KJ2017A707]

作者

  • Y

    Yu, Ming-jun (第一作者)

  • L

    Li, Chao

    anhui med univ

查看全部 5 位作者收起作者
  • D

    Deng, Sheng-song

  • M

    Meng, Xiao-ming

    anhui med univ

  • Y

    Yao, Ri-sheng (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417